The UroLift® System is a minimally invasive device designed to treat lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). It is designed to open the urethra directly by retracting the obstructing prostatic lobes without applying incisions, surgical resection or thermal injury to the prostate.
How It Works:
A trained physician inserts the UroLift delivery device transurethrally through a rigid sheath (not shown) under cystoscopic visualization to reach the targeted area of obstruction.
- The physician carefully determines the precise location to place each permanent UroLift implant. S/he uses the UroLift delivery device in an attempt to retract the obstructing prostatic lobes and deploy a needle that comes out of the delivery device to deliver the permanent implant.
The physician removes the UroLift delivery device and sheath, with the goal of leaving an expanded urethral lumen. The exact number of implants required is determined by the trained physician and can vary depending on the size and shape of the prostatic obstruction.
Click here to view an animation of the procedure.
Click here to view the UroLift devices.
(Images courtesy of Dr. Peter Chin, Wollongong, NSW, Australia)
- Endoscopic results can be immediately confirmed post-procedure.
- The procedure may be performed under local or general anesthesia.
- UroLift system does not preclude the option for future TURP should one be indicated
Click here to read about UroLift system clinical publications.